GALWAY, IRELAND--March 19, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Bristol-Myers Squibb Company (BMS) (NYSE:BMY) (New York, New York) has opted to build its first European sterile drug product (SDP) facility in Dublin, Ireland. Within this article: Details $400 million investment in Dublin operations to build a sterile drug facility, timeline, products, existing operations
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
